Long-acting injectable HIV treatment given every 2 months was safe, well tolerated, and strongly preferred by adolescents in a recent study.
Aditya Gaur, MD
Advertisement
Aditya Gaur, MD, is a medical director at St. Jude Children’s Research Hospital.
Articles by Aditya Gaur, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Prenatal paracetamol (acetaminophen) not linked to autism, ADHD, or intellectual disability
2
Adolescents report a preference for long-acting injectable HIV therapy
3
INTEGUMENT-PED trial shows consistent efficacy of roflumilast cream in children aged 2 to 5
4
Jonathan Miller, MD, talks starting HPV vaccination earlier to improve cancer prevention
5